A majority now say it is likely the meeting between President Donald Trump and Kim Jong Un in Singapore will “slow or stop” North Korea’s nuclear weapons program.
A Rasmussen Reports national survey finds 51% think it’s likely including 23% who say it is “very likely.” This compares to 38% and 12% respectively just two months ago. Another 28% say it is at least “somewhat likely.”
Twenty-five percent (25%) said it was “not very likely” and only 14% said it’s “not at all likely” to halt the program.
When asked if his strategy and posture during his dealings with North Korea, 43% said President Trump’s response has been “about right” and only 29% say he’s been “too aggressive.”
The announcement of the “highly anticipated meeting” comes shortly after Secretary of State Mike Pompeo took his second known trip to the country to secure the release of three Americans previously detained by North Korea.
Mr. Pompeo’s first trip to the country came during Easter weekend. It was meant to gauge the potential for and viability of a summit, which would be the first-ever between the U.S. and North Korea after more than six decades of hostility.
Shortly after Mr. Pompeo returned to the U.S., Kim announced that he suspended Pyongyang’s nuclear testing program, including a freeze on intercontinental ballistic missile tests and closing a nuclear site.
The survey of 1,000 likely voters in the U.S. was conducted on May 10-13, 2018 by Rasmussen Reports. The margin of sampling error is +/- 3 percentage points with a 95% level of confidence. See methodology.
The most damning journalistic sin committed by the media during the era of Russia collusion…
The first ecological study finds mask mandates were not effective at slowing the spread of…
On "What Are the Odds?" Monday, Robert Barnes and Rich Baris note how big tech…
On "What Are the Odds?" Monday, Robert Barnes and Rich Baris discuss why America First…
Personal income fell $1,516.6 billion (7.1%) in February, roughly the consensus forecast, while consumer spending…
Research finds those previously infected by or vaccinated against SARS-CoV-2 are not at risk of…
This website uses cookies.